Reduction of corticosteroid use in outpatient treatment of exacerbated COPD – Study protocol for a randomized, double-blind, non-inferiority study (The “RECUT”-Trial)

Abstract excerpt

<title>Abstract</title> <p>Background Chronic obstructive pulmonary disease (COPD) is a major public health issue affecting approximately four to seven percent of the Swiss population. According to current inpatient guidelines, systemic corticosteroids are important in the treatment of acute COPD exacerbations and should be given for five to seven days. Several studies suggest that corticosteroids accelerate the...

Topics

Open a Topic to create a Post that cites this publication.

• Adrenal Cortex Hormones
• Adrenergic beta-2 Receptor Agonists
• Androstadienes
• Bronchodilator Agents
• Double-Blind Method
• Muscarinic Antagonists
• Practice Guidelines as Topic
• Pulmonary Disease, Chronic Obstructive

Identifiers and source

Literature Corpus work

6cf6abb1-1c79-5e9c-8fa6-15a26fada57f

DOI

10.21203/rs.2.13106/v2